Literature DB >> 11502822

Abdominal visceral fat and fasting insulin are important predictors of 24-hour GH release independent of age, gender, and other physiological factors.

J L Clasey1, A Weltman, J Patrie, J Y Weltman, S Pezzoli, C Bouchard, M O Thorner, M L Hartman.   

Abstract

Numerous physiological factors modulate GH secretion, but these variables are not independent of one another. We studied 40 younger (20-29 yr.; 21 men and 19 women) and 62 older (57-80 yr.; 35 men and 27 women) adults to determine the contributions of several demographic and physiological factors to the variability in integrated 24-h GH concentrations. Serum GH was measured every 10 min for 24 h in an enhanced sensitivity chemiluminescence assay. The predictor variables included: age group (young or old), gender, abdominal visceral fat (by computed tomography), total body fat mass and percentage body fat by dual-energy x-ray absorptiometry, serum IGF-I, fasting serum insulin, 24-h mean estradiol and testosterone, and peak oxygen uptake by graded exercise (treadmill) testing. Multiple ordinary least squares regression analysis was used to quantitatively assess the individual contribution that each predictive measure made to explain the variability among values of integrated 24-h GH concentrations while in the presence of the remaining predictors. The model explained 65% of the variance in integrated 24-h GH concentrations. Abdominal visceral fat (P < 0.002) and fasting insulin (P < 0.008) were consistently important predictors of integrated 24-h GH concentrations independent of age group, gender, and all other predictor variables. Although serum IGF-I was an important overall predictor of integrated 24-h GH concentrations (P = 0.002), this relationship was present only in the young subjects and was modulated by gender. The remaining variables failed to contribute significantly to the model. We conclude that abdominal visceral fat and fasting insulin are important predictors of integrated 24-h GH concentrations in healthy adults, independent of age and gender. Serum IGF-I is an important predictor of integrated 24-h GH concentrations in young but not older subjects. Bidirectional feedback between each of these three factors and GH secretion may account for the strong relationships observed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11502822     DOI: 10.1210/jcem.86.8.7731

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  38 in total

Review 1.  Neuroendocrine control of GH release during acute aerobic exercise.

Authors:  A Weltman; L Wideman; J Y Weltman; J D Veldhuis
Journal:  J Endocrinol Invest       Date:  2003-09       Impact factor: 4.256

Review 2.  Hormone replacement therapy and physical function in healthy older men. Time to talk hormones?

Authors:  Manthos G Giannoulis; Finbarr C Martin; K Sreekumaran Nair; A Margot Umpleby; Peter Sonksen
Journal:  Endocr Rev       Date:  2012-03-20       Impact factor: 19.871

3.  Diagnosis: a reappraisal of the diagnosis of growth hormone deficiency.

Authors:  Gudmundur Johannsson
Journal:  Nat Rev Endocrinol       Date:  2010-04       Impact factor: 43.330

4.  Anthropometry, CT, and DXA as predictors of GH deficiency in premenopausal women: ROC curve analysis.

Authors:  Miriam A Bredella; Andrea L Utz; Martin Torriani; Bijoy Thomas; David A Schoenfeld; Karen K Miller
Journal:  J Appl Physiol (1985)       Date:  2008-12-18

Review 5.  Pathophysiology of GHRH-growth hormone-IGF1 axis in HIV/AIDS.

Authors:  Shobhit Jain; Ninad Desai; Amrit Bhangoo
Journal:  Rev Endocr Metab Disord       Date:  2013-06       Impact factor: 6.514

Review 6.  Obesity: Current and potential pharmacotherapeutics and targets.

Authors:  Vidya Narayanaswami; Linda P Dwoskin
Journal:  Pharmacol Ther       Date:  2016-10-20       Impact factor: 12.310

Review 7.  Idiopathic adult growth hormone deficiency.

Authors:  Shlomo Melmed
Journal:  J Clin Endocrinol Metab       Date:  2013-03-28       Impact factor: 5.958

8.  The decreased growth hormone response to growth hormone releasing hormone in obesity is associated to cardiometabolic risk factors.

Authors:  Fernando Cordido; Jesús Garcia-Buela; Susana Sangiao-Alvarellos; Teresa Martinez; Ovidio Vidal
Journal:  Mediators Inflamm       Date:  2010-01-21       Impact factor: 4.711

9.  Effects of continuous versus intermittent exercise, obesity, and gender on growth hormone secretion.

Authors:  Arthur Weltman; Judy Y Weltman; Dee Dee Watson Winfield; Kirsten Frick; James Patrie; Petra Kok; Daniel M Keenan; Glenn A Gaesser; Johannes D Veldhuis
Journal:  J Clin Endocrinol Metab       Date:  2008-09-09       Impact factor: 5.958

10.  Impaired IGF1-GH axis and new therapeutic options in Alström Syndrome patients: a case series.

Authors:  Cristina Maria Mihai; Doina Catrinoiu; Marius Toringhibel; Ramona Mihaela Stoicescu; Negreanu-Pirjol Ticuta; Hancu Anca
Journal:  Cases J       Date:  2009-01-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.